For clinicians prescribing GLP-1s

Know what is covered before you write the order.

Manoa is a clinical decision support tool that catches the payer detail, missing chart fact, or coverage change that turns a clean plan into rework — before your staff starts the prior auth.

Request pilot access

Works without PHI. No EHR integration. Free tier available.

Access-aware consult

Rank semaglutide versus tirzepatide for a patient with Class II obesity and T2D. Show the cleanest path to approval and what documentation is missing before I send this to staff.

Draft Treatment Plan

Case JR-2041

Recommended

Semaglutide (Ozempic)

Preferred on this plan with the cleanest first-pass approval path.

Next steps for staff

Attach Metformin GI distress note
Verify Jan 2026 A1c for handoff
Queue patient education

30-45 min

Spent per GLP-1 coverage lookup today (AMA 2024)

<5 min

Target with Manoa decision support

46%

Of denials from missing info, not clinical ineligibility

The real problem

The hard part is never choosing a GLP-1 in the abstract.

You already know the drug class.

The hard part is knowing what this specific plan changed last quarter, which chart detail is missing, and what will bounce back after clinic.

The real work starts when the visit is over.

Chart review, prior-failure proof, payer rules, step-therapy documentation — after hours, alone, with no guarantee the first pass will stick.

Your staff needs a handoff, not a summary.

If the rationale lives only in your head, someone still has to translate it into action items. The useful output lands on their desk, not yours.

Generic AI is not the bottleneck.

Any chatbot can summarize a trial. The harder job is catching the payer condition or missing chart fact that changes what you actually order.

How it helps

Before you order, it looks for the detail that changes the plan.

A conversational intake catches the missing detail. Decision support ranks options by clinical fit and coverage likelihood. The Draft Treatment Plan carries the rationale and next steps to your staff.

if A1c above 8.5%

if Prior GLP-1 intolerance

if Non-preferred plan update

Conversational intake

Catch the chart detail that turns a clean plan into rework

Manoa asks focused follow-up questions one at a time — lab values, prior failures, contraindications — so the Draft Treatment Plan is grounded before it reaches your staff.

1Semaglutide

preferred

2Tirzepatide

preferred

Coverage-aware decision support

See the cleanest path for this payer, not just the best drug on paper

Every option is ranked by clinical fit plus likely coverage friction, with evidence citations attached, so you can see what has a real path forward for the plan in front of you.

Staff-ready Draft Treatment Plan

Give your team a handoff they can use without another message thread

The output is a Draft Treatment Plan with a Next Steps checklist your MA or nurse can act on directly — not a summary they have to reinterpret.

Trust boundary

Useful on day one. Honest about the edges.

What Manoa does

Works without PHI so you can evaluate value before routing protected data anywhere.
Asks focused follow-up questions one at a time and grounds each option in cited source material, current policy logic, and the facts shown in the thread.
Produces a Draft Treatment Plan with evidence citations and a Next Steps checklist office staff can act on directly.

What Manoa does not do

Provide medical advice or replace clinical judgment — it is decision support, not a recommendation engine.
Require PHI, an EHR integration, or hospital IT approval before the product becomes useful.
Guarantee approval, invent coverage terms, or reason beyond the sources shown in the thread.

Request pilot access

If GLP-1 starts are spilling past clinic hours, this is the pilot.

See if it earns a place in your day before anyone asks you to scope an integration project.

Best fit today is primary care, obesity medicine, and endocrinology teams. If you work in another specialty and the same medication-access pain shows up in your day, you can still request access.

Work email only. No EHR integration required to evaluate the pilot.

If GLP-1 starts are spilling past clinic hours, this is the pilot.

See if it earns a place in your day before anyone asks you to scope an integration project.

Best fit today is primary care, obesity medicine, and endocrinology teams. If you work in another specialty and the same medication-access pain shows up in your day, you can still request access.

Work email only. No EHR integration required to evaluate the pilot.